Merit Financial Group, LLC Moderna, Inc. Transaction History

Merit Financial Group, LLC

$4.65 Billion
Q2 2024

A detailed history of Merit Financial Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 2,154 shares of MRNA stock, worth $141,625. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,154

Previous 2,986 27.86%

Holding current value

$141,625

Previous $318,000 19.81%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $84,206 - $138,619	-832 Reduced 27.86%	2,154 $255,000
Q1 2024 May 06, 2024	SELL	$85.37 - $115.44 $30,306 - $40,981	-355 Reduced 10.63%	2,986 $318,000
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $54,843 - $82,395	-789 Reduced 19.1%	3,341 $332,000
Q3 2023 Nov 07, 2023	BUY	$96.41 - $126.61 $8,966 - $11,774	93 Added 2.3%	4,130 $426,000
Q2 2023 Aug 01, 2023	BUY	$118.5 - $160.53 $151,917 - $205,799	1,282 Added 46.53%	4,037 $490,000
Q1 2023 Apr 24, 2023	SELL	$135.66 - $197.02 $1.35 Million - $1.96 Million	-9,924 Reduced 78.27%	2,755 $423,000
Q4 2022 Jan 13, 2023	SELL	$118.38 - $210.04 $34,566 - $61,331	-292 Reduced 2.25%	12,679 $0
Q3 2022 Oct 31, 2022	SELL	$118.07 - $194.18 $334,256 - $549,723	-2,831 Reduced 17.92%	12,971 $1.53 Million
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $1.61 Million - $2.42 Million	13,711 Added 655.71%	15,802 $2.26 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $100,029 - $185,924	791 Added 60.85%	2,091 $360,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $38,389 - $62,646	170 Added 15.04%	1,300 $330,000
Q3 2021 Oct 27, 2021	BUY	$221.9 - $484.47 $41,051 - $89,626	185 Added 19.58%	1,130 $435,000
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $122,764 - $222,056	945 New	945 $222,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.

Account

Merit Financial Group, LLC Moderna, Inc. Transaction History